-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
JPMorgan Chase & Co. Increases Stock Holdings in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB)
JPMorgan Chase & Co. raised its stake in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) by 221.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 97,660 shares of the company’s stock after acquiring an additional 67,325 shares during the period. JPMorgan Chase & Co.’s holdings in Y-mAbs Therapeutics were worth $765,000 as of its […]
JPMorgan Chase & Co. raised its stake in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) by 221.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 97,660 shares of the company’s stock after acquiring an additional 67,325 shares during the period. JPMorgan Chase & Co.’s holdings in Y-mAbs Therapeutics were worth $765,000 as of its […]
